title: Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
authors.forename: François
authors.initials: F
authors.lastname: Montastruc
authors.forename: Guillaume
authors.initials: G
authors.lastname: Montastruc
authors.forename: Philippe
authors.initials: P
authors.lastname: Vigreux
authors.forename: Patrick
authors.initials: P
authors.lastname: Bruneval
authors.forename: Céline
authors.initials: C
authors.lastname: Guilbeau-Frugier
authors.forename: Christophe
authors.initials: C
authors.lastname: Cron
authors.forename: Haleh
authors.initials: H
authors.lastname: Bagheri
authors.forename: Bernadette
authors.initials: B
authors.lastname: Delisle
authors.forename: Maryse
authors.initials: M
authors.lastname: Lapeyre-Mestre
authors.forename: Atul
authors.initials: A
authors.lastname: Pathak
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Montastruc
mesh_terms: D000328:Adult; D006213:Hallucinogens / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008944:Mitral Valve Insufficiency / Q000139:chemically induced* / Q000473:pathology; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine